- Fate Therapeutics (NASDAQ:FATE): Q2 EPS of -$0.29 beats by $0.03.
- Revenue of $1.03M (+212.1% Y/Y) beats by $0.16M.
- Shares -3.5%.
- Press Release
Fate Therapeutics beats by $0.03, beats on revenue
Recommended For You
More Trending News
About FATE Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| FATE | - | - |
| Fate Therapeutics, Inc. | ||